Who Supplies Febuxostat? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Febuxostat exports, with 182+ registered manufacturers shipping to buyers across 91+ countries — yet a handful of companies dominate the shipments. AJANTA PHARMA LIMITED holds the largest share at 30.5% (export value: $14.9M). Close behind, LUPIN LIMITED (7.6%, $3.7M). ALEMBIC PHARMACEUTICALS LIMITED (5.3%, $2.6M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Febuxostat? Top Manufacturers & Their Buyers
Flow of Febuxostat from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Febuxostat Supplier Network — Key Market Intelligence
The Febuxostat export market from India is led by AJANTA PHARMA LIMITED, which alone commands a 30.5% share, shipping $14.9M worth of product across 89 shipments. The second-largest exporter, LUPIN LIMITED, contributes $3.7M (7.6%) to the overall market. Combined, the top two suppliers alone account for 38.1% of all Febuxostat exports, indicating a relatively concentrated supply base.
Across all 182 tracked manufacturers, the total Febuxostat export value stands at $48.9M from 3.5K shipments. The market average shipment value is $14.0K. The single largest buyer relationship in terms of trade value is AJANTA PHARMA PHILIPPINES INC, receiving $7.6M worth of product.
The combined buyer network spans 19 named purchasing companies, including AJANTA PHARMA PHILIPPINES INC, UNILAB INC, RITEMED PHILS. INC., DELTA IMPORT - EXPOR, MULTICARE PHARMACEUTICALS PHILIPPIN and 14 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the first-largest Febuxostat exporter from India, with a market share of 30.5% and a total export value of $14.9M across 89 shipments. Their average shipment value of $167.6K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. AJANTA PHARMA PHILIPPINES INC is the dominant customer, accounting for 51.2% of this supplier's tracked business. Top customers include:
• AJANTA PHARMA PHILIPPINES INC — $7.6M across 46 shipments (51.2% of this supplier's total exports)
• UNILAB INC — $7.1M across 42 shipments (47.3% of this supplier's total exports)
• RITEMED PHILS. INC. — $175.7K across 1 shipments (1.2% of this supplier's total exports)
• DELTA IMPORT - EXPOR — $32.8K across 0 shipments (0.2% of this supplier's total exports)
• RITEMED PHILS. INC. — $18.8K across 0 shipments (0.1% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $167.6K is 1098% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
2LUPIN LIMITED
LUPIN LIMITED is the second-largest Febuxostat exporter from India, with a market share of 7.6% and a total export value of $3.7M across 30 shipments. Their average shipment value of $124.0K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
LUPIN LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MULTICARE PHARMACEUTICALS PHILIPPIN — $1.6M across 13 shipments (42.0% of this supplier's total exports)
• MULTICARE PHARMACEUTICALS PHILIPPIN — $1.2M across 9 shipments (31.3% of this supplier's total exports)
• MULTICARE PHARMACEUTICALS PHILIPPIN — $729.7K across 6 shipments (19.6% of this supplier's total exports)
• MULTICARE PHARMACEUTICALS PHILIPPIN — $209.9K across 2 shipments (5.6% of this supplier's total exports)
• J D S CO LTD NO 9 YA — $53.4K across 0 shipments (1.4% of this supplier's total exports)
Key Insight: LUPIN LIMITED's per-shipment value of $124.0K is 786% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
3ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the third-largest Febuxostat exporter from India, with a market share of 5.3% and a total export value of $2.6M across 56 shipments. Their average shipment value of $46.3K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• J KNIPPER COMPANY — $1.1M across 25 shipments (44.2% of this supplier's total exports)
• J KNIPPER COMPANY — $786.3K across 17 shipments (30.3% of this supplier's total exports)
• J KNIPPER COMPANY — $271.7K across 6 shipments (10.5% of this supplier's total exports)
• J KNIPPER COMPANY — $211.9K across 5 shipments (8.2% of this supplier's total exports)
• J. KNIPPER & COMPANY — $178.2K across 4 shipments (6.9% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $46.3K is 231% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
4MSN LABORATORIES PRIVATE LIMITED
MSN LABORATORIES PRIVATE LIMITED is the fourth-largest Febuxostat exporter from India, with a market share of 5.2% and a total export value of $2.5M across 342 shipments. Their average shipment value of $7.4K is below the market average of $14.0K, reflecting a high-volume, competitive pricing strategy.
MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 58.7% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $1.5M across 201 shipments (58.7% of this supplier's total exports)
• NOVADOZ PHARMACEUTICALS LLC — $607.5K across 82 shipments (24.0% of this supplier's total exports)
• SCOTT HEALTH LTD — $237.2K across 32 shipments (9.4% of this supplier's total exports)
• SCOTT HEALTH LIMITED — $101.2K across 14 shipments (4.0% of this supplier's total exports)
• MSN LABS AMERICAS SA — $98.5K across 13 shipments (3.9% of this supplier's total exports)
Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (342 shipments) at a per-shipment value of $7.4K, indicating a broad distribution network with many smaller, regular orders.
5EMCURE PHARMACEUTICALS LIMITED
EMCURE PHARMACEUTICALS LIMITED is the fifth-largest Febuxostat exporter from India, with a market share of 3.1% and a total export value of $1.5M across 52 shipments. Their average shipment value of $28.8K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
EMCURE PHARMACEUTICALS LIMITED serves 5 named buyers in our database. MARCAN PHARMACEUTICALS INC. is the dominant customer, accounting for 67.2% of this supplier's tracked business. Top customers include:
• MARCAN PHARMACEUTICALS INC. — $1.0M across 35 shipments (67.2% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC. — $232.8K across 8 shipments (15.5% of this supplier's total exports)
• MARCAN PHARMACEUTICALS INC. — $131.3K across 5 shipments (8.8% of this supplier's total exports)
• TILLOMED LABORATORIE — $79.6K across 3 shipments (5.3% of this supplier's total exports)
• TILLOMED LABORATORIE — $48.7K across 2 shipments (3.2% of this supplier's total exports)
Key Insight: EMCURE PHARMACEUTICALS LIMITED's per-shipment value of $28.8K is 106% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
6MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the fifth-largest Febuxostat exporter from India, with a market share of 2.7% and a total export value of $1.3M across 68 shipments. Their average shipment value of $19.1K is above the market average of $14.0K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MACLEODS PHARMA UK LIMITED — $524.3K across 27 shipments (40.3% of this supplier's total exports)
• JAMP PHARMA CORPORATION — $336.4K across 18 shipments (25.9% of this supplier's total exports)
• MACLEODS PHARMA USA, — $175.2K across 9 shipments (13.5% of this supplier's total exports)
• HEUMANN PHARMA GMBH — $133.7K across 7 shipments (10.3% of this supplier's total exports)
• PHARMACEUTICAL INSTI — $130.7K across 7 shipments (10.0% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $19.1K is 37% above the market average of $14.0K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Febuxostat Flows
Once Febuxostat leaves the manufacturing plants of companies like AJANTA PHARMA LIMITED and LUPIN LIMITED, it travels to 5 destination markets with a combined import value of $48.9M. Philippines absorbs the largest share at 52.3% ($25.6M), followed by United States (23.7%) and Canada (4.8%).
In Philippines — the top destination — named importers include UNILAB INC, AJANTA PHARMA PHILIPPINES INC, MULTICARE PHARMACEUTICALS. In United States, key buyers are J. KNIPPER & COMPANY,, J KNIPPER COMPANY, J. KNIPPER & COMPANY.
This geographic spread reflects Febuxostat's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Febuxostat Go? Top Importing Countries & Their Buyers
Trade flow of Febuxostat exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Philippines
Philippines ranks as the first-largest destination for Febuxostat imports from India, with a total trade value of $25.6M across 95 shipments — representing a 52.3% share of all Febuxostat exports. The average shipment value of $269.2K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Febuxostat importers in Philippines: UNILAB INC is the largest buyer, accounting for 34.6% ($8.9M) of this market's total imports.
• UNILAB INC — $8.9M (34.6% of Philippines's total)
• AJANTA PHARMA PHILIPPINES INC — $7.6M (29.8% of Philippines's total)
• MULTICARE PHARMACEUTICALS — $3.9M (15.3% of Philippines's total)
Key Insight: Philippines's per-shipment average of $269.2K (1824% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Febuxostat imports from India.
2United States
United States ranks as the second-largest destination for Febuxostat imports from India, with a total trade value of $11.6M across 98 shipments — representing a 23.7% share of all Febuxostat exports. The average shipment value of $118.4K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.
Named Febuxostat importers in United States: J. KNIPPER & COMPANY, is the largest buyer, accounting for 23.4% ($2.7M) of this market's total imports.
• J. KNIPPER & COMPANY, — $2.7M (23.4% of United States's total)
• J KNIPPER COMPANY — $1.3M (11.5% of United States's total)
• J. KNIPPER & COMPANY — $840.4K (7.2% of United States's total)
Key Insight: United States's per-shipment average of $118.4K (746% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Febuxostat imports from India.
3Canada
Canada ranks as the third-largest destination for Febuxostat imports from India, with a total trade value of $2.4M across 26 shipments — representing a 4.8% share of all Febuxostat exports. The average shipment value of $91.1K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Febuxostat importers in Canada: MARCAN PHARMACEUTICALS INC is the largest buyer, accounting for 42.5% ($1.0M) of this market's total imports.
• MARCAN PHARMACEUTICALS INC — $1.0M (42.5% of Canada's total)
• MARCAN PHARMACEUTICALS INC. — $574.2K (24.3% of Canada's total)
• JAMP PHARMA CORPORATION — $362.1K (15.3% of Canada's total)
Key Insight: Canada's per-shipment average of $91.1K (551% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Febuxostat imports from India.
4Hungary
Hungary ranks as the fourth-largest destination for Febuxostat imports from India, with a total trade value of $1.3M across 20 shipments — representing a 2.7% share of all Febuxostat exports. The average shipment value of $66.9K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Febuxostat importers in Hungary: TEVA PHARMACEUTICALS WORKS PVT LTD is the largest buyer, accounting for 62.8% ($840.6K) of this market's total imports.
• TEVA PHARMACEUTICALS WORKS PVT LTD — $840.6K (62.8% of Hungary's total)
• TEVA PHARMACEUTICALS WORKS PRIVATE LIMITED — $497.3K (37.2% of Hungary's total)
Key Insight: Hungary's per-shipment average of $66.9K (378% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Hungary is a key market for Febuxostat imports from India.
5United Kingdom
United Kingdom ranks as the fifth-largest destination for Febuxostat imports from India, with a total trade value of $1.2M across 16 shipments — representing a 2.5% share of all Febuxostat exports. The average shipment value of $75.9K is above the global average of $14.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Febuxostat importers in United Kingdom: MACLEODS PHARMA UK LIMITED is the largest buyer, accounting for 47.8% ($581.0K) of this market's total imports.
• MACLEODS PHARMA UK LIMITED — $581.0K (47.8% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $75.9K (442% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Febuxostat imports from India.
People Also Ask — Febuxostat Supplier & Trade Network
Who are the top suppliers of Febuxostat from India?+
Which companies buy Febuxostat from Indian manufacturers?+
Where does Febuxostat exported from India go?+
What is the market share of the top Febuxostat supplier from India?+
What is the average shipment value for Febuxostat exports from India?+
Is Febuxostat manufactured in India and exported globally?+
Which country imports the most Febuxostat from India?+
Who are the buyers of Febuxostat in United States?+
How concentrated is the Febuxostat supplier market in India?+
How do I find verified buyers for Febuxostat in specific countries?+
Febuxostat Trade Network — Key Takeaways
- 1AJANTA PHARMA LIMITED is India's dominant Febuxostat exporter with a 30.5% market share and $14.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 182 suppliers collectively account for 54.3% of all tracked Febuxostat exports, with a combined trade value of $48.9M.
- 3Philippines is the largest destination market, absorbing 52.3% of India's Febuxostat exports ($25.6M). United States (23.7%) and Canada (4.8%) follow.
- 4With 3.5K total shipments averaging $14.0K each, the Febuxostat export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AJANTA PHARMA PHILIPPINES INC, UNILAB INC, MULTICARE PHARMACEUTICALS PHILIPPIN, MULTICARE PHARMACEUTICALS PHILIPPIN — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 91 countries
Network value: $48.9M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Febuxostat — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Febuxostat.
- 2.Flow Mapping: 182 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,494 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 91 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,494 Verified Shipments
182 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists